The company also named healthcare veteran Steve Fanning as Chief Executive Officer and a member of the Board of Directors.

This latest infusion of capital and new leadership will enable the company to rapidly scale to meet growing healthcare industry demand for Highlight, its patented portfolio of products for improving cleaning and safety by visibly coloring the disinfectants hospitals currently use. Current and new investors include family offices and funds like Pioneer Healthcare Partners, Kapor Center, and Partnership Fund for NYC and former industry leaders from Abbott, Baxalta, Baxter, Bayer, Becton Dickinson, Cantel, Ecolab, Intermountain Healthcare, NorthShore University HealthSystem, and Walgreens, among others.

Founded during the Ebola outbreak in West Africa, Kinnos is pioneering ways to more optimally employ proven disinfectants for a safer healing environment amidst a rising tide of infections globally. The company's flagship product is Highlight, a patented, award-winning, and hospital-grade color additive platform that improves technique and compliance for the gold standard in disinfection. Already in use by hospitals, first responders, and transit agencies around the world, Highlight's real-time color visualization platform has been shown in independent studies to consistently increase thoroughness of cleaning.